ES2234689T3 - Procedimiento de preparacion de composiciones de antibioticos a base de carbapenemo. - Google Patents

Procedimiento de preparacion de composiciones de antibioticos a base de carbapenemo.

Info

Publication number
ES2234689T3
ES2234689T3 ES00974020T ES00974020T ES2234689T3 ES 2234689 T3 ES2234689 T3 ES 2234689T3 ES 00974020 T ES00974020 T ES 00974020T ES 00974020 T ES00974020 T ES 00974020T ES 2234689 T3 ES2234689 T3 ES 2234689T3
Authority
ES
Spain
Prior art keywords
temperature
solution
approximately
formulation
vials
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES00974020T
Other languages
English (en)
Spanish (es)
Inventor
Anthony Al-Dehneh
William A. Hunke
Kathleen J. Illig
Anand Kanike
Hiren Patel
Scott D. Reynolds
Stelios C. Tsinontides
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Application granted granted Critical
Publication of ES2234689T3 publication Critical patent/ES2234689T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/02—Preparation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicinal Preparation (AREA)
ES00974020T 1999-10-29 2000-10-27 Procedimiento de preparacion de composiciones de antibioticos a base de carbapenemo. Expired - Lifetime ES2234689T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16248299P 1999-10-29 1999-10-29
US162482P 1999-10-29

Publications (1)

Publication Number Publication Date
ES2234689T3 true ES2234689T3 (es) 2005-07-01

Family

ID=22585803

Family Applications (1)

Application Number Title Priority Date Filing Date
ES00974020T Expired - Lifetime ES2234689T3 (es) 1999-10-29 2000-10-27 Procedimiento de preparacion de composiciones de antibioticos a base de carbapenemo.

Country Status (8)

Country Link
EP (1) EP1244444B1 (enExample)
JP (1) JP4854899B2 (enExample)
AT (1) ATE285770T1 (enExample)
AU (1) AU770165B2 (enExample)
CA (1) CA2388163C (enExample)
DE (1) DE60017194T2 (enExample)
ES (1) ES2234689T3 (enExample)
WO (1) WO2001032172A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6548492B1 (en) * 1999-10-29 2003-04-15 Merck & Co., Inc. Process for formulation of carbapenem antibiotic compositions
JP2005522422A (ja) * 2002-02-01 2005-07-28 シモダ、バイオテック（プロプライエタリー）リミテッド 医薬組成物
EP2505191A1 (en) * 2008-06-11 2012-10-03 Ranbaxy Laboratories Limited Lyophilized Carbapenem antibiotic composition
US8691803B2 (en) 2011-01-24 2014-04-08 Savior Lifetec Corporation Process for the preparation of antibiotic compounds
US10016383B2 (en) 2013-05-07 2018-07-10 Mcmaster University Inhibitors of metallo-β-lactamase-enzymes
KR101587420B1 (ko) * 2014-08-20 2016-01-22 주식회사 대웅제약 에르타페넴-함유 동결건조제제의 제조방법
KR20170014842A (ko) 2015-07-31 2017-02-08 주식회사 대웅제약 개선된 에르타페넴 주사제의 제조방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP970281B1 (en) * 1996-05-28 2002-04-30 Merck & Co Inc Carbapenem antibiotic, composition and method of preparation
UA62920C2 (en) * 1996-05-28 2004-01-15 Merck & Co Inc Carbapeneme antibiotic, a composition and a method for the preparation
CA2268820A1 (en) * 1996-10-28 1998-05-07 Merck & Co., Inc. Stabilized carbapenem antibiotic compositions and method of making
US6297231B1 (en) * 1996-10-28 2001-10-02 Merck & Co., Inc. Stabilized carbapenem antibiotic compositions and method of making
JP3245427B2 (ja) * 1997-06-16 2002-01-15 メルク エンド カンパニー インコーポレーテッド 安定化されたカルバペネム中間体および合成における使用

Also Published As

Publication number Publication date
ATE285770T1 (de) 2005-01-15
WO2001032172A1 (en) 2001-05-10
CA2388163A1 (en) 2001-05-10
JP2003514779A (ja) 2003-04-22
EP1244444B1 (en) 2004-12-29
CA2388163C (en) 2009-08-25
AU1245601A (en) 2001-05-14
DE60017194T2 (de) 2005-12-22
DE60017194D1 (de) 2005-02-03
EP1244444A1 (en) 2002-10-02
JP4854899B2 (ja) 2012-01-18
AU770165B2 (en) 2004-02-12
EP1244444A4 (en) 2003-05-21

Similar Documents

Publication Publication Date Title
ES2202729T3 (es) Hormona paratiroidea cristalina.
ES2298672T3 (es) Composiciones que contienen piperacilina y tazobactam utiles para inyeccion.
ES2215992T3 (es) Composiciones cristalinas de amofostina y metodos para su preparacion y uso.
US9662397B2 (en) Lipopeptide compositions and related methods
ES2293637T3 (es) Formulacion de la hormona paratiroidea.
ES2295166T3 (es) Procedimiento para la formulacion de compuestos antibioticos.
ES2210121T3 (es) Preparacion farmaceutica estable, que puede ser utilizada por via nasal, oral o sublingual que contiene desmopresina.
ES2234689T3 (es) Procedimiento de preparacion de composiciones de antibioticos a base de carbapenemo.
ES2215183T3 (es) Disoluciones inyectables o de infusion de enrofloxacino.
US10342769B2 (en) Carmustine pharmaceutical composition
ES2301685T3 (es) Disoluciones de paracetamol para inyeccion listas para usar que contienen propilenglicol como unico codisolvente.
ES2368758T3 (es) Formulación de argatroban que incluye un ácido como solubilizante.
AU2001261079A1 (en) Process for formulation of antibiotic compounds
ES2686898T3 (es) Composición para inyección
EP3402463A1 (en) Formulations of vancomycin
US5972912A (en) Method for lyophilizing ifosfamide
CN108187060B (zh) 药物载体、药物制剂及制备方法
EP2440180B1 (en) Ipamorelin diacetate injection and infusion solutions
US6486150B2 (en) Process for formulation of antibiotic compounds
US12208061B2 (en) Sterile aztreonam package
CA3235585A1 (en) Liquid pharmaceutical formulation